Skip to main content

Advertisement

Log in

Autoimmune Lymphoproliferative Syndrome: Response to Mycophenolate Mofetil and Pyrimethamine/Sulfadoxine in a 5-Year-Old Child

  • Case Report
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

Autoimmune Lymphoproliferative Syndrome (ALPS) is a rare inherited disorder of disrupted lymphocyte homeostasis characterized by chronic splenomegaly and lymphadenopathy of early onset, hypergammaglobulinemia (Ig G and Ig A), autoimmune phenomena, and expanded populations of TCR-α/β+, CD3+, CD4-, CD8-T cells (Fisher et al. Cell 81:935–946; 1995), called double negative T-cells [(DN) T cells]. We discuss a case of ALPS which showed good response to immunosuppressant drug Mycophenolate-Mofetil in combination with Pyrimethamine/Sulfadoxine.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin Y, Strober W, Lenardo MJ, Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81(6):935–946

    Article  PubMed  CAS  Google Scholar 

  2. Vaishnaw AK, Orlinick JR, Chu JL et al (1999) The molecular basis for apoptotic defects in patients with CD 95 (FAS- APO-1) mutations. J Clin Invest 103(3):355–363

    Article  PubMed  CAS  Google Scholar 

  3. Drappa J, Vaishnaw AK, Sullivan KE et al (1996) FAS gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity. N Engl J Med 335(22):1643–1649

    Article  PubMed  CAS  Google Scholar 

  4. Rieux-Laucat F, Blanche S, Danielan S et al (1999) Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 94(8):2575–2582

    PubMed  CAS  Google Scholar 

  5. Stroncek D, Daleb JK, Straus SE (2003) Autoimmune lymphoproliferative syndrome: An inherited disorder with a high incidence of autoimmune cytopenias. Transfus Med Hemother 30:270–275

    Article  Google Scholar 

  6. Lim MS, Straus SE, Dale JK, Fleisher TA, Stetler-Stevenson M, Strober W et al (1998) Pathological findings in human auto immune lymphoproliferative syndrome. Am J Pathol 153:1541–1550

    Article  PubMed  CAS  Google Scholar 

  7. Worth A, Thrasher AJ, Gasper HB (2006) Auto immune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Hemotol 133:124–140

    Article  CAS  Google Scholar 

  8. Rao VK, DF DaleJK, Davis J, Tretler J, Hurley JK, Fleisher T et al (2005) Use of mycophenolate mofitil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome. Br J Haematol 129:534–538

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We would like to acknowledge, Dr. Vikram Mathews and Ms Reena Rajasekhar for processing the Immunophenotyping sample at Christian Medical College, Vellore.

Conflict of Interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Neeraj Singh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arora, S., Singh, N., Chaudhary, G.K. et al. Autoimmune Lymphoproliferative Syndrome: Response to Mycophenolate Mofetil and Pyrimethamine/Sulfadoxine in a 5-Year-Old Child. Indian J Hematol Blood Transfus 27, 101–103 (2011). https://doi.org/10.1007/s12288-011-0058-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-011-0058-2

Keywords

Navigation